Vanguard Personalized Indexing Management
REGN icon

Vanguard Personalized Indexing Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.3M Sell
11,712
-921
-7% -$627K 0.06% 264
2026
Q1 		$9.76M Buy
12,633
+660
+6% +$505K 0.1% 178
2025
Q4 		$9.24M Buy
11,973
+901
+8% +$612K 0.09% 178
2025
Q3 		$6.23M Buy
11,072
+219
+2% +$124K 0.06% 260
2025
Q2 		$5.7M Buy
10,853
+792
+8% +$442K 0.06% 261
2025
Q1 		$6.38M Sell
10,061
-130
-1% -$89.4K 0.09% 185
2024
Q4 		$7.26M Sell
10,191
-414
-4% -$347K 0.11% 154
2024
Q3 		$11.1M Buy
10,605
+1,046
+11% +$1.16M 0.18% 95
2024
Q2 		$10M Buy
9,559
+1,129
+13% +$1.09M 0.19% 87
2024
Q1 		$8.11M Buy
8,430
+386
+5% +$367K 0.17% 95
2023
Q4 		$7.06M Buy
8,044
+75
+0.9% +$61.8K 0.18% 96
2023
Q3 		$6.56M Buy
7,969
+810
+11% +$637K 0.2% 82
2023
Q2 		$5.14M Buy
7,159
+253
+4% +$195K 0.16% 104
2023
Q1 		$5.67M Buy
6,906
+560
+9% +$422K 0.2% 92
2022
Q4 		$4.58M Buy
6,346
+152
+2% +$112K 0.19% 100
2022
Q3 		$4.27M Buy
6,194
+966
+18% +$608K 0.19% 88
2022
Q2 		$3.09M Buy
5,228
+1,281
+32% +$833K 0.14% 126
2022
Q1 		$2.76M Buy
3,947
+1,166
+42% +$738K 0.13% 134
2021
Q4 		$1.76M Buy
2,781
+441
+19% +$271K 0.1% 196
2021
Q3 		$1.42M Buy
2,340
+461
+25% +$286K 0.13% 157
2021
Q2 		$1.05M Buy
1,879
+667
+55% +$338K 0.11% 187
2021
Q1 		$573K Buy
1,212
+16
+1% +$7.79K 0.09% 281
2020
Q4 		$578K Sell
1,196
-48
-4% -$25.9K 0.13% 189
2020
Q3 		$696K Buy
1,244
+144
+13% +$87.3K 0.2% 125
2020
Q2 		$686K Buy
1,100
+59
+6% +$33.5K 0.31% 74
2020
Q1 		$508K Buy
+1,041
New +$429K 0.3% 93

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Vanguard Personalized Indexing Management's REGN Position: Q2 2026 in Review

Vanguard Personalized Indexing Management reduced its Regeneron Pharmaceuticals (REGN) stake by 7.3% in Q2 2026, selling an estimated $627K and leaving 11,712 shares worth $7.3M. The position accounts for 0.06% of the portfolio, ranked #264.

Vanguard Personalized Indexing Management first reported a position in REGN in Q1 2020 and has held it in 26 quarters since. The position peaked at $11.1M in Q3 2024. 1,333 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Vanguard Personalized Indexing Management held 11,712 shares of Regeneron Pharmaceuticals worth $7.3M as of Q2 2026.
  • Vanguard Personalized Indexing Management sold 921 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $627K.
  • Regeneron Pharmaceuticals made up 0.06% of Vanguard Personalized Indexing Management's portfolio in Q2 2026, its #264 holding.
  • Vanguard Personalized Indexing Management first reported a position in Regeneron Pharmaceuticals in Q1 2020 and has held it in 26 quarters since.
  • Vanguard Personalized Indexing Management's Regeneron Pharmaceuticals position peaked at $11.1M in Q3 2024.
  • 1,333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Vanguard Personalized Indexing Management's 13F filing for Q2 2026, filed 11 Aug 2026.